Yunxiang Zhou

9PUBLICATIONS
9CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Epidemiological methodsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 20, 2026
Recent Advances in Antibody-Drug Conjugates and Immunotherapy Combinations for Treatment of Triple-Negative Breast Cancer.

Huihui Chen, Wei Lu, Yunxiang Zhou

|Feb 02, 2026
A Highly Sensitive and High-Throughput Quantitative HILIC-MS/MS Method for Systematic Profiling of RNA Modifications.

Cheng Guo, Xiujuan Hong, Yiqiu Hu

|Oct 13, 2025
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER).

Yunxiang Zhou, Zhiyun Zhang, Huihui Chen

|Sep 12, 2025
Investigation of Thrombocytopenia Associated with Trastuzumab Emtansine Treatment in Breast Cancer: A Retrospective Study in a Chinese Population.

Kun Zhang, Shijie Wu, Yunxiang Zhou

|Nov 29, 2023
Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study.

Yunxiang Zhou, Xianan Guo, Lu Shen

|Jul 06, 2023
Margetuximab: An active alternative for later-line therapy in patients with HER2-positive advanced breast cancer.

Yunxiang Zhou, Xiaojia Wang, Yiding Chen

Pageof 2

Frequent Collaborators

2 joint publications

Yiding Chen

1 joint publications

John H Zhang

1 joint publications

Anwen Shao

1 joint publications

Xianjun Xuan